Fibromyalgia Identification and Diagnosis
Transcription
Fibromyalgia Identification and Diagnosis
Fibromyalgia Identification and Diagnosis PBP00930O © 2010 Pfizer Inc. All rights reserved. Printed in USA/May 2010 Chronic Pain and Fibromyalgia Pathophysiology of Fibromyalgia Clinical Features and Diagnosis of Fibromyalgia 2 The Burden of Chronic Pain • Pain is the most common reason for physician visits1 – Roughly 1 in 5 adults suffers from chronic pain2,3 • Chronic pain has detrimental effects – Impaired daily activities, lost work productivity2,4 – Poorer general health, increased risk for cardiovascular morbidity, depression, anxiety2,3,5,6 – Greater health care utilization7 – Erosion of trust in health care providers8 – Negative effect on partner/caregiver9 • Fibromyalgia (FM) is a chronic, widespread pain condition that is distinct from other types of chronic pain10 1. Abbott FV, Fraser MI. J Psychiatry Neurosci. 1998;23(1):13-34. 2. Smith BH et al. FamPract. 2001;18(3):292-299. 3. Gureje O et al. JAMA. 1998;280(2):147-151. 4. Stewart WF et al. JAMA. 2003;290(18):2443-2454. 5. Chung OY et al. Anesth Analg. 2008;107(3):1018-1025. 6. Bruehl S et al. Clin J Pain. 2005;21(2):147-153. 7. Blyth FM et al. Pain. 2004;111(1-2):51-58. 8. Waters D, Sierpina VS. Pain Physician. 2006;9(4):353-360. 9. Reich JW et al. Arthritis Rheum. 2006;55(1):86-93. 10. Woolf C. Ann Intern Med. 2004;140(6):441-451. 3 C FM Is a Chronic Pain Condition and Is Distinct from Other Types of Pain1 Pain is the most common reason for physician visits2 Nociceptive Pain Neuropathic Pain Inflammatory Pain Central Pain Amplification (eg, burns, cuts) (eg, herpes zoster, pDPN) (eg, rheumatoid arthritis, psoriatic arthritis) (eg, FM) Painful Stimuli Neuronal Damage Inflammation Abnormal Pain Processing by CNS pDPN=painful diabetic peripheral neuropathy. 1. Woolf C. Ann Intern Med. 2004;140(6):441-451. 2. Abbott FV, Fraser MI. J Psychiatry Neurosci. 1998;23(1):13-34. 4 C FM Is Characterized by Chronic Widespread Pain and Tenderness1 • American College of Rheumatology (ACR) criteria for the classification of FM include2: – Chronic widespread pain (core feature) for ≥3 months • Pain above and below the waist • Pain on left and right sides of body • Pain in the axial skeleton – Pain at ≥11 of 18 tender points when palpated with 4 kg/cm2 of digital pressure • New preliminary diagnostic criteria are intended as an alternative to, not a replacement for, the ACR criteria3 Diagram Showing 18 Tender Points The ACR criteria are2: • Sensitive (88.4%) – proportion of patients correctly identified as having the condition • Specific (81.1%) – proportion of patients correctly identified as not having the condition 1. Wolfe F et al. Arthritis Rheum. 1995;38(1):19-28. 2. Wolfe F et al. Arthritis Rheum. 1990;33(2):160-172. 3. Wolfe F et al. Arthritis Care Res. 2010;62(5):600-610. 5 C FM Epidemiology and Risk Factors • Prevalence of FM in United States is estimated to be 2% to 5% of the adult population1,2 – FM is often underdiagnosed/misdiagnosed3 – Diagnosis takes an average of 5 years4 • Most common in individuals aged 25 to 60 years5 • Risk factors include: – Genetic: increased incidence among first-degree relatives, associated with genetic markers6,7 – Environmental: physical trauma, infections, social stressors8 – Gender: more common in women1,5,9 1. 2. 3. 4. Wolfe F et al. Arthritis Rheum. 1995;38(1):19-28. Lawrence RC et al. Arthritis Rheum. 2008;58(1):26-35. Buurma AK et al. Fibromyalgia. Waltham, MA: Decision Resources; July 2009. National Fibromyalgia Association Web site. www.fmaware.org/site/ PageServer?pagename=fibromyalgia_diagnosed. Accessed January 27, 2010. 5. 6. 7. 8. 9. Weir PT et al. J Clin Rheumatol. 2006;12(3):124-128. Arnold LM et al. Arthritis Rheum. 2004;50(3):944-952. Buskila D, Sarzi-Puttini P. Arthritis Res Ther. 2006;8(5):218. Mease PJ. J Rheumatol. 2005;32(suppl 75):6-21. Wolfe F, Rasker JJ. Fibromyalgia. In: Kelley’s Textbook of Rheumatology. Philadelphia, PA: Saunders; 2008: chap 38. 6 The Clinical Challenge: Patient Cycling Contributes to Underdiagnosis Dx with comorbid condition ~5 million individuals with FM symptoms1 94% present to HCP2 Refer or switch HCP In a practice with 30 patients/day, 1-3 may have FM symptoms3 Cycling4 (average of 5 years5) Tx but then re-present Overall diagnosis rate is low2 Switch/add Tx; switch/add Dx Obstacles to Earlier Diagnosis4,5 No definitive laboratory tests for diagnosis FM not suspected early in “cycling” process Multiple symptoms Confounding comorbidities Symptom descriptions do not always facilitate diagnosis HCP=health care provider. 1. Lawrence RC et al. Arthritis Rheum. 2008;58(1):26-35. 2. Buurma AK et al. Fibromyalgia. Waltham, MA: Decision Resources; July 2009. 3. Turk D, McCarberg B. The Black Book of Fibromyalgia. New York, NY: MBL Communications, Inc; 2009. 4. Data on file. Pfizer Inc, New York, NY. 5. National Fibromyalgia Association Web site. www.fmaware.org/site/PageServer?pagename= fibromyalgia_diagnosed. Accessed January 27, 2010. 7 Chronic Pain and FM: Summary • FM is a distinct chronic pain disorder characterized by widespread pain and tenderness1 • In the United States, FM affects 2% to 5% of adults2,3 • FM is challenging to diagnose; rate of diagnosis is low4 • Diagnosis takes an average of 5 years5 1. 2. 3. 4. 5. Wolfe F et al. Arthritis Rheum. 1990;33(2):160-172. Wolfe F et al. Arthritis Rheum. 1995;38(1):19-28. Lawrence RC et al. Arthritis Rheum. 2008;58(1):26-35. Buurma AK et al. Fibromyalgia. Waltham, MA: Decision Resources; July 2009. National Fibromyalgia Association Web site. www.fmaware.org/site/ PageServer?pagename=fibromyalgia_diagnosed. Accessed January 27, 2010. 8 Chronic Pain and Fibromyalgia Pathophysiology of Fibromyalgia Clinical Features and Diagnosis of Fibromyalgia Conducting the Manual Tender Point Survey 9 C Central Amplification: Leading Theory for Abnormal Pain Processing in FM Perceived pain Ascending input Normal Pain Processing Descending modulation Pain stimuli Nociceptive afferent fiber Perceived pain (hyperalgesia/allodynia) Increased release of glutamate and substance P Pain Processing in FM Decreased release of norepinephrine and serotonin Pain amplification Woolf CJ. Ann Intern Med. 2004;140(6):441-451. Gottschalk A, Smith DS. Am Fam Physician. 2001;63(10):1979-1986. Induction of central amplification leading to abnormal pain processing Minimal stimuli 10 C FM: An Amplified Pain Response Subjective Pain Intensity 10 Pain in FM 8 Hyperalgesia 6 (eg, when a pinprick causes an intense stabbing sensation) 4 Allodynia Pain amplification response Normal Pain Response (eg, hugs that feel painful) 2 0 Stimulus Intensity Adapted from Gottschalk A, Smith DS. Am Fam Physician. 2001;63(10):1979-1986. 11 C fMRI Study Supports the Amplification of Normal Pain Response in Patients With FM Patients with FM experienced high pain with low-grade stimuli 14 Pain Intensity 12 Overlapping regions of brain activation were seen in patients with FM after low pain stimuli and in normal subjects after high pain stimuli 10 8 6 4 2 0 1.5 2.5 3.5 Stimulus Intensity, kg/cm2 FM (n=16) Subjective pain control Stimulus pressure control 4.5 Red: Activated by low-intensity stimulus in FM patients (n=16) Blue: Activated only by high-intensity stimulus in controls Yellow: Area of overlapping activation fMRI=functional magnetic resonance imaging. Gracely RH et al. Arthritis Rheum. 2002;46(5):1333-1343. 12 Elevated Substance P and Glutamate Are Found in CSF of FM Patients Pain Neurotransmitter Levels 50 42.8 40 P<.001 30 20 16.3 10 0 FM Patient (n=32) Glutamate2 Glutamate Concentration, µg/mL Substance P Concentration, fmoles/mL† Substance P1* Control (n=30) 2.5 2.36 P<.003 2.0 1.37 1.5 1.0 0.5 0 FM Patient (n=20) Control (n=20) *CSF (cerebrospinal fluid) sample collected via lumbar puncture in FM and healthy controls and substance P levels assessed by radioimmunoassay. † fmoles/mL = femtomole/mL = 10-15 mole/mL. 1. Russell IJ et al. Arthritis Rheum. 1994;37(11):1593-1601. 2. Sarchielli P et al. J Pain. 2007;8(9):737-745. 13 Pathophysiology of FM: Summary • Central amplification is a leading theory of FM pathophysiology1 • fMRI data support FM as a disorder of central pain amplification2 – Areas activated by high-intensity stimuli in control patients were activated by low-intensity stimuli in patients with FM • Elevated pain neurotransmitters (eg, substance P, glutamate) seen in patients with FM3-5 – May contribute to pain amplification 1. Staud R, Rodriguez ME. Nat Clin Pract Rheum. 2006;2(2):90-98. 2. Gracely RH et al. Arthritis Rheum. 2002;46(5):1333-1343. 3. Russell IJ et al. Arthritis Rheum. 1994;37(11):1593-1601. 4. Bradley LA et al. Arthritis Rheum. 1996;(suppl 9):212. Abstract 1109. 5. Sarchielli P et al. J Pain. 2007;8(9):737-745. 14 Chronic Pain and Fibromyalgia Pathophysiology of Fibromyalgia Clinical Features and Diagnosis of Fibromyalgia Conducting the Manual Tender Point Survey 15 C Clinical Presentation of FM • Chronic widespread pain and tenderness are the defining features of FM1-3 • FM is often accompanied by sleep disturbance and fatigue2 • Patients with FM may also present with other comorbid symptoms or conditions, including1,3,4: – – – – – – IBS Cognitive dysfunction Numbness or tingling Mood disorders Morning stiffness Headaches/migraines IBS=irritable bowel syndrome. 1. Wolfe F et al. Arthritis Rheum. 1995;38(1):19-28. 2. Wolfe F, Rasker JJ. Fibromyalgia. In: Kelley’s Textbook of Rheumatology. Philadelphia, PA: Saunders; 2008. 3. Mease P. J Rheumatol. 2005;32(suppl 75):6-21. 4. Weir PT et al. J Clin Rheumatology.2006;12(3):124-128. 16 C Clinical Features of FM Pain • Pain in all 4 quadrants of the body, including1: Location Duration – Pain above and below the waist, on the left and right sides of the body, and in the axial skeleton • Chronic, lasting at least 3 months1 • Allodynia: pain experienced from nonpainful stimuli2 – eg, hugs, handshakes Quality • Hyperalgesia: an amplified response to painful stimuli2 – eg, pinprick, stubbed toe • Patient descriptors of pain3,4 – “Flu-like,” “dull,” “aching” Pain/Tenderness Measures • Manual Tender Point Survey (MTPS) exam5 • Visual analog scale (VAS), numeric rating scale (NRS), pain diagram2,3,6 Other • Pain worsens with overactivity, stress, life events2,3 1. Wolfe F et al. Arthritis Rheum. 1990;33(2):160-172. 2. Wolfe F, Rasker JJ. Fibromyalgia. In: Kelley’s Textbook of Rheumatology. Saunders; 2008. 3. Goldenberg DL. Clinical Management of Fibromyalgia. West Islip, NY: Professional Communications, Inc; 2009. 4. Staud R. Arthritis Res Ther. 2006;8(3):208-214. 5. Okifuji A et al. J Rheumatol. 1997;24(2):377-383. 6. Johnson C. J Chiropr Med. 2005;4(1):43-44. 17 C FM Often Seen With Other Chronic Medical Conditions1-5 Other Pain States • IBS • Pelvic pain syndromes • Painful bladder syndrome (interstitial cystitis) • Headaches/migraines • Neck and back pain Infection and Inflammation • Hepatitis C • Lyme disease • Crohn’s disease Psychological Disorders • Depression • Anxiety disorders • Posttraumatic stress disorder Rheumatic Disorders • Osteoarthritis • Rheumatoid arthritis • Systemic lupus erythematosus Consider FM in patients with chronic conditions who also suffer from chronic widespread pain, fatigue, and sleep disturbance 1. Chakrabarty S, Zoorob R. Am Fam Physician. 2007;76(2):247-254. 2. Wolfe F, Rasker JJ. Fibromyalgia. In: Kelley’s Textbook of Rheumatology. Philadelphia, PA: Saunders; 2008. 3. Weir PT et al. J Clin Rheumatol. 2006;12(3):124-128. 4. Mease P. J Rheumatol. 2005;32(suppl 75):6-21. 5. Hershfield NB. Can J Gastroenterol. 2005;19(4):231-234. 18 C Diagnosing FM: ACR Classification Criteria According to ACR criteria, FM can be diagnosed if patient has: 1. Widespread pain for ≥3 months in all 4 quadrants of body1 – Widespread pain is defined as: • Pain above and below the waist • Pain on the left and right sides of the body • Pain in the axial skeleton 2. Pain on palpation in ≥11 of 18 tender points1 – MTPS provides standardized approach to tender point assessment2 The ACR criteria are1: • Sensitive (88.4%) – proportion of patients correctly identified as having the condition • Specific (81.1%) – proportion of patients correctly identified as not having the condition 1. Wolfe F et al. Arthritis Rheum. 1990;33(2):160-172. 2. Okifuji A et al. J Rheumatol. 1997;24(2):377-383. 19 Preliminary Diagnostic Criteria for FM According to the preliminary criteria, FM can be diagnosed based on an HCP-administered questionnaire: 1. Widespread pain index (WPI) – The number of painful body regions 2. Symptom severity (SS) scale that assesses the severity of: – – – – Fatigue Waking unrefreshed Cognitive symptoms Quantifies the occurrence of other somatic symptoms 3. Pain and symptoms present for 3 months or longer The preliminary criteria: • Not meant to replace current ACR classification criteria, but to offer an alternative method of FM diagnosis • Accurately identified 88% of the same FM cases initially identified by the 1990 ACR classification criteria Wolfe F et al. Arthritis Care Res. 2010;62(5):600-610. 20 C Clinical Approach to FM Diagnosis 1. Patient history – Chronic widespread pain for ≥3 months1 – Multiple visits with pain, fatigue, sleep complaints2 – Other associated conditions/symptoms2 • IBS, morning stiffness, migraines, mood disorders, etc 2. MTPS exam3 (refer to slides for specific instructions on conducting the physical exam) 3. Other physical exam and/or lab assessments to rule out or establish coexistence of other disorders2 1. Wolfe F et al. Arthritis Rheum. 1990;33(2):160-172. 2. Mease PJ. J Rheumatol. 2005;32(suppl 75):6-21. 3. Okifuji A et al. J Rheumatol. 1997;24(2):377-383. 21 Telltale Descriptions of FM: Listening to Patients Common descriptions of FM symptoms from patients1,2 “I feel like I always have the flu.” “No matter how much sleep I’ve had, I always feel like a truck ran me over when I wake up.” “I hurt all over.” “I’m always tired and run-down.” 1. Wolfe F et al. Arthritis Rheum. 1990;33(2):160-172 2. Goldenberg DL. Clinical Management of Fibromyalgia. West Islip, NY: Professional Communications, Inc; 2009. 22 Identifying Widespread Pain in Possible FM Patients Pain drawings can help identify widespread pain in possible FM patients1 Pain severity can be evaluated using assessment scales2,3 Visual Analog Scale (VAS)2* No pain Very severe pain *Actual scale should be 100 mm in length. Numeric Rating Scale (NRS)3 No pain Back 1 2 3 4 5 6 7 8 9 10 Most pain Front Adapted from pain drawing provided courtesy of L Bateman. 1. Silverman SL, Martin SA. In: Wallace DJ, Clauw DJ, eds. Fibromyalgia & Other Central Pain Syndromes. Philadelphia, PA: Lippincott, Williams & Wilkins; 2005:309-319. 2. Bigatti SM, Cronan TA. J Nurs Meas. 2002;10(1):5-14. 3. Johnson C. J Chiropr Med. 2005;4(1):43-44. 23 Importance of “Seeing” the Whole Patient When Diagnosing FM • Specialists often diagnose from the viewpoint of their training • PCPs have the opportunity to look at the whole patient The psychiatrist sees depression The otolaryngologist sees TMJ syndrome The gastroenterologist sees IBS The gynecologist sees PMS The cardiologist sees noncardiac chest pain Weir PT et al. J Clin Rheumatology. 2006;12(3):124-128. The rheumatologist sees FM The neurologist sees chronic headache 24 Differentiating Selected Conditions From FM: Key Clues to Make a Confident Diagnosis Condition Clinical Presentation Typical Patient Characteristics Diagnostic Tests FM Chronic widespread pain; sleep disturbance; morning stiffness; IBS; fatigue; headache; mood symptoms F > M (2-9:1) Onset: 25-60 y 2%-5% of US adults MTPS, labs typically within normal limits Myofascial pain syndrome Localized muscle pain arising from trigger points; muscle stiffness; sleep disturbance Onset: 27-50 y 45%-54% Palpation of trigger points Osteoarthritis Stiffness; gelling; crepitus; joint pain (knee, hip, hand)* Onset: ↑ with age† ~12%† Radiographs DIP/PIP nodules Hypothyroidism Weight gain; cold intolerance; fatigue; muscle aches F > M (2-8:1) ~5% Serum TSH Rheumatoid arthritis Symmetric swelling of joints, insidious onset; morning stiffness (>1 hour) F > M (2-3:1) Onset: 30-50 y ~0.5%-1% RF, anti-CCP, ESR, CRP, radiographs Polymyalgia rheumatica Weakness; pain in girdle muscles (neck, shoulders, thighs); stiffness F > M (2:1) Onset: >50 y 0.5-0.7% ESR, CRP, response to prednisolone Systemic lupus erythematosus Photosensitivity; fever; skin rash; fatigue; joint/muscle pain F > M (9:1) Onset: 15-44 y ~0.05% ANA, ESR, CRP, anti-DNA Polymyositis Symmetric proximal muscle weakness; pain F > M (2-3:1) Onset: >20 y (esp 45-60) ~0.005%-0.01% CPK, EMG Data from Goldman L, Ausiello D. Cecil Textbook of Medicine. 23rd ed. Philadelphia, PA: Saunders Elsevier; 2007, unless otherwise noted. *Hunter DJ et al. Rheum Dis Clin North Am. 2008;34(3):623-643. †Bitton R. Am J Manag Care. 2009;15(8 suppl):S230-S235. 25 Diagnosis of FM Results in Reduced Health Care Utilization and Associated Costs − Testing increases considerably in 5 years before diagnosis − Rates decline or stabilize after diagnosis 200 FM Case Matched Control 150 95% CI 100 FM is associated with heavy utilization of health care resources for at least 10 years prior to diagnosis2 FM Diagnosis 50 − Labs and imaging − Physician referrals − Medications • Rate of Diagnostic Testing* Per 100 Person-Years: FM vs Control2 Failure to diagnose FM can lead to excessive costs1 Rate per 100 Person-Years • -10 -5 0 5 Years Relative to Index Date *Diagnostic testing defined as all laboratory tests requested by general practitioner (UK study). 1. Annemans L et al. Arthritis Rheum. 2008;58(3):895-902. 2. Hughes G et al. Arthritis Rheum. 2006;54(1):177-183. 26 Patient Satisfaction and Health Status Improves After FM Diagnosis – Allows patients to begin appropriate therapy • Improves health status over the long term2 – Greater satisfaction with health – Lesser number of major and minor symptoms Failure to diagnose FM can: • Aggravate symptoms3 • Promote distrust of health care providers and fear regarding missed diagnosis3 Lesser 4 satisfaction Patient Health Dissatisfaction A diagnosis of FM: • Brings a sense of relief to patients1 Greater satisfaction Patient Satisfaction Improves After an FM Diagnosis2 3.0 Lower number indicates improved patient satisfaction 3 2.2 * 2 1 0 Baseline Postdiagnosis n=100 *Statistically significant vs baseline (P value not provided) as a change in the 5-point Likert scale. 1. Undeland M, Malterud K. Scand J Prim Health Care. 2007;25(4):250-255. 2. White KP et al. Arthritis Rheum. 2002;47(3):260-265. 3. Goldenberg DL. Clinical Management of Fibromyalgia. West Islip, NY: Professional Communications, Inc; 2009. 27 Clinical Features and Diagnosis of FM: Summary • Chronic widespread pain and tenderness are the defining features of FM1,2 – Often accompanied by sleep disturbance, fatigue, other comorbidities • The FM diagnosis should be based on patient characteristics, not on exclusion3 • FM diagnosis guided by: – Patient-reported symptoms4 – History of chronic widespread pain1 – MTPS exam5 • Abnormal laboratory values should trigger an investigation of co-occurring conditions4 • Receiving an FM diagnosis reduces costs and improves health status6,7 1. Wolfe F et al. Arthritis Rheum. 1990;33(2):160-172. 2. Wolfe F et al. Arthritis Rheum. 1995;38(1):19-28. 3. Chakrabarty S, Zoorob R. Am Fam Physician. 2007;76(2):247-254. 4. Mease P. J Rheumatol. 2005;32(suppl 75):6-21. 5. Okifuji A et al. J Rheumatol. 1997;24(2):377-383. 6. White KP et al. Arthritis Rheum. 2002;47(3):260-265. 7. Altomonte L et al. Reumatismo. 2008;60(suppl 1):70-78. 28